NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Stock Market Update: Key Developments and Earnings

The Indian stock market is set for a busy trading session today, with several companies reporting their quarterly earnings and updates on significant investments, deals, and order wins. Here are the key highlights from the market:

Quarterly and Yearly Business Update

  • Jubilant FoodWorks reported a 19.1% year-over-year (YoY) growth in consolidated revenue to Rs 2,505.8 crore, with standalone revenue increasing 6.2% to Rs 1,686 crore.
  • Domino’s India recorded a like-for-like growth of 0.2%, while Domino’s Turkey reported a like-for-like growth of 9%.
  • Fino Payments Bank added around 7 lakh new accounts, taking its total customer base to 1.75 crore, and saw a 96% growth in loan referral QoQ, with disbursements reaching around Rs 600 crore through partner institutions.
  • CreditAccess Grameen reported a 14% YoY growth in gross loan portfolio to Rs 29,590 crore, with disbursements soaring 28% to Rs 8,313 crore.
  • Gallantt Ispat saw a 14% YoY growth in power production to 2.23 lakh mega units, with pellets production surging 59% to 2.21 lakh MT and sponge production rising 38% to 2.44 lakh MT.
  • Godrej Consumer Products expects a double-digit underlying sales growth, high-single digit underlying volume growth, and standalone EBITDA margins to sustain within the normative range.
  • PC Jeweller reported a standalone revenue growth of 32% and successfully reduced its outstanding debt by 23% under the terms of the Joint Settlement Agreement.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Stocks to Watch

  • Aurobindo Pharma: The company's subsidiary, CuraTeQ Biologics, announced positive topline results from its Phase 3 study of BP11, an investigational biosimilar to Xolair (omalizumab).
  • ACME Solar Holdings: The company commissioned the fifth phase of 76 MW / 160.512 MWh out of the total 285 MW / 601.904 MWh capacity of its Battery Energy Storage System (BESS) project in Jaisalmer, Rajasthan.
  • PDS: The global fashion infrastructure platform entered into a Sourcing-as-a-Service (SaaS) contract with a leading US-based value retailer, with the potential to drive sourcing volumes of approximately Rs 450 crore.

Bulk Deals

  • CKK Retail Mart: Craft Emerging Market Fund PCC sold 3.54 lakh shares (1.82 percent stake) for Rs 4.43 crore at a price of Rs 125 per share.
  • Striders Impex: Upsurge Opportunities Fund 1 sold 1.39 lakh shares (0.74 percent stake) for Rs 93.26 lakh, while Longthrive Capital VCC sold 96,000 shares (0.51 percent stake) for Rs 64.32 lakh.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

SME Listing

  • Vivid Electromech: Stock Trades Ex-Bonus
  • Avax Apparels and Ornaments: Stock in F&O Ban
  • Sammaan Capital:

Investor Takeaway

Investors should keep an eye on Jubilant FoodWorks' quarterly earnings and Fino Payments Bank's loan referral growth.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.